A report prepared for 340B Health and published by L&M Policy Research shows that 340B hospitals care for a greater proportion of the underserved and low-income patient population than non-340B…
Last week, the U.S. District Court for the Southern District of Florida held that Sentry Data Systems Inc. can proceed in an antitrust lawsuit against CVS Pharmacy, Inc., alleging that…
On April 1, 2019, HRSA launched its secure pricing component of the 340B OPAIS. This long overdue website allows safety-net providers access to a database of 340B ceiling prices. The…
RWC-340B will be scheduling Hill visits for members that are traveling to DC to attend SYNChronicity 2019. RWC-340B Hill visits will take place Tuesday, April 16, from about 1:00pm to…
You will probably recall that Powers asked the HRSA HIV/HIV/AIDS Bureau (HAB) for guidance recently on whether Ryan White program income may be used to purchase mobile vans to be…
The Trump administration’s fiscal year (FY) 2020 budget request, released on Monday, February 11, includes potentially harmful changes to the 340B program, increased funding for HIV/AIDS (although at the expense…
This week, a report was released by the Community Access National Network (CANN), an organization created and sponsored by PhRMA and several pharmaceutical manufacturers. The stated goal of the report…
On February 28, 2019, the U.S. Department of Health and Human Services (HHS) filed a status report with the U.S. District Court for the District of Columbia regarding its progress…
A recent report from the CDC tracking HIV trends in the U.S. from 2010 to 2016 shows that after five years of dramatic decline, the number of annual HIV infections…
On February 26, 2019, top executives from seven of the largest pharmaceutical companies testified before the Senate Finance Committee attempting to defend the industry’s business practices. The major focus of…